AI English summary of an SEC filing — figures as filed
Clorox CLXClorox said net sales and volume for the 3 months ended December 31, 2024 both decreased 15%, while both increased 2% for the 6 months, citing as factors the lapping of retail inventory restoration following the August 2023 cyberattack and the divestitures of the Better Health VMS and Argentina businesses.
Key points
AI summaryClorox said net sales and volume for the 3 months ended December 31, 2024 both decreased 15%, while both increased 2% for the 6 months, citing as factors the lapping of retail inventory restoration following the August 2023 cyberattack and the divestitures of the Better Health VMS and Argentina businesses.
Clorox said gross margin rose from 43.5% to 43.8% for the 3 months and from 41.4% to 44.8% for the 6 months. Advertising costs as a percentage of net sales increased 200 basis points for the 3 months and 100 basis points for the 6 months.
Clorox said diluted net earnings per share increased $0.79, or 105%, for the 3 months and $1.42, or 154%, for the 6 months. The effective tax rate was 18.1% for the 3 months, compared with 29.3% in the prior period, and 28.2% for the 6 months, compared with 26.7% in the prior period.
The company said net cash provided by operations for the 6 months was $401, compared with $173 in the prior period, and net cash used for financing activities was $346, compared with $104 in the prior period. During the 3 and 6 months, it repurchased 906 and 1,695 thousand shares at a cost of $150 and $257, respectively.
Key figures
Quarter ended December 31, 2024
- Revenue
- $1.7B
- Net income
- $193M
- EPS
- $1.54
- Gross profit
- $738M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Quarterly and Half-Year Net Sales and Volume Changes
Clorox said net sales and volume for the 3 months ended December 31, 2024 both decreased 15%, while both increased 2% for the 6 months, citing as factors the lapping of retail inventory restoration following the August 2023 cyberattack and the divestitures of the Better Health VMS and Argentina businesses.
Source · Based on the MD&A text of the filing
Gross Margin and Advertising Spending as Percentage of Net Sales
Clorox said gross margin rose from 43.5% to 43.8% for the 3 months and from 41.4% to 44.8% for the 6 months. Advertising costs as a percentage of net sales increased 200 basis points for the 3 months and 100 basis points for the 6 months.
Source · Based on the MD&A text of the filing
Diluted Earnings Per Share and Effective Tax Rate Changes
Clorox said diluted net earnings per share increased $0.79, or 105%, for the 3 months and $1.42, or 154%, for the 6 months. The effective tax rate was 18.1% for the 3 months, compared with 29.3% in the prior period, and 28.2% for the 6 months, compared with 26.7% in the prior period.
Source · Based on the MD&A text of the filing
Cash Flow and Share Repurchases for the 6 Months
The company said net cash provided by operations for the 6 months was $401, compared with $173 in the prior period, and net cash used for financing activities was $346, compared with $104 in the prior period. During the 3 and 6 months, it repurchased 906 and 1,695 thousand shares at a cost of $150 and $257, respectively.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…